Default Category
-
Volkswagen AG: Valuation in 2009 (A)
Saffi, Pedro; Vergara, CarlesCase F-845-EFinanceThe purpose of this case is to introduce two of the most basic and used valuation techniques: dividend discount model (DDM) and multiples valuation. Students are required to value Volkswagen AG in the context of its merger agreement with Porsche and a major economic crisis that strongly affected the car industry. This case is designed for use at the beginning of a standard MBA Corporate Finance course, but can also be placed in any valuation modu...Starting at €8.20
-
Volkswagen AG: valoración en 2009 (A)
Saffi, Pedro; Vergara, CarlesCase F-845FinanceEl presente caso se propone presentar dos de las técnicas de valoración más elementales y usadas con mayor frecuencia: el modelo de descuento de dividendos (DDM) y la valoración de múltiplos. Los estudiantes deben valorar Volkswagen AG en el contexto de su acuerdo de fusión con Porsche y una profunda crisis económica que ha golpeado con fuerza la industria automovilística. Este caso está pensado para usar al principio de un curso MBA estándar sob...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Squeeze to Infinity: Porsche's Attempt to Acquire Volkswagen
Saffi, Pedro; Simon, JanCase F-848-EFinanceThe German financial market regulator (BaFin) had recently come under severe national and international pressure because of large market movements in Volkswagen stocks, caused by Porsche's announcement that it acquired a much larger than expected stake in the company. At one point, the firm had become the largest company in the world and, in one afternoon, its market capitalization was bigger than that of the entire car industry. In the blame gam...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20